Cancer Talk Blog

Francisco Hernandez-Ilizaliturri, MD, Professor of Oncology and Director of Lymphoma Research in Roswell Park’s Department of Medicine

Could Venetoclax Improve Outcomes of CAR T for Patients with Resistant B-Cell Lymphomas? New Insights at ASH

About a third of patients with diffuse large B cell lymphoma (DLBCL), a fast-growing form of lymphoma, will see their disease advance or recur following treatment. Seeking a new treatment strategy that might boost the effectiveness of existing DLBCL therapies, a team from Roswell Park has been working to understand the underlying mechanisms of the targeted chemotherapy venetoclax.

Monday, December 9, 2024 - 07:00 am

Authors Jens Hillengass, MD, PhD, and Janine Joseph, MS, MBA,

News

Resistance Training Can Reduce Fatigue, Pain in Multiple Myeloma Patients, Roswell Park Team Shows

In a talk at the 66th American Society of Hematology Annual Meeting, researchers from Roswell Park are presenting compelling findings showcasing significant benefits of resistance training for patients with multiple myeloma.

Sunday, December 8, 2024 - 07:00 am

News

Roswell Park Experts Report Insights on CAR T for Follicular Lymphoma, KEYNOTE-667 Combo in Hodgkin Lymphoma

The results of two important lymphoma studies led by experts at Roswell Park will be presented during oral abstract sessions this morning at the 66th annual meeting of the American Society of Hematology (ASH) in San Diego, California. Lymphoma is a type of blood cancer that causes white blood cells called lymphocytes to grow out of control and behave abnormally.

Sunday, December 8, 2024 - 07:00 am

News

Roswell Park Study Reveals How Venetoclax Boosts Immune Response to CAR T for Chronic Lymphocytic Leukemia

Research led by Roswell Park's Dr. Matthew Cortese has shed light on how the drug venetoclax works synergistically with CAR T-cell immunotherapy to combat chronic lymphocytic leukemia (CLL), the most common type of leukemia in the U.S.

Saturday, December 7, 2024 - 07:00 am

News

Preclinical Study Shows Targeted Drug Strengthens the Power of CAR T-Cell Therapy in Two Pediatric Leukemias

A preclinical study led by Roswell Park faculty member Lisa Niswander, MD, PhD, shows that gilteritinib can strengthen CAR T-cell immunotherapy in two high-risk pediatric leukemias that have poor survival rates.

Saturday, December 7, 2024 - 07:00 am

Pediatric patient and 2024 Tree of Hope lighter Willow McMurray poses on a playground

Article

Meet Willow, this year’s Tree of Hope lighter

Willow McMurray was having a great time playing softball with her summer team, like any 10-year-old might, when she started complaining about pain in her hands and elbows.

Thursday, December 5, 2024 - 10:30 am

Patient Stories

Article

Can the mercury in dental fillings cause cancer?

While amalgams are a safe dental restoration method, mercury itself can be toxic to humans at certain levels of exposure.

Tuesday, December 3, 2024 - 09:20 am

Cancer Research & News

Three people stand together in a room. The woman in the middle wears a head scarf.

News

Tomorrow’s Promise, Today’s Roswell Park: Leaders Tackling the Biggest Priorities in Cancer Care and Treatment

Roswell Park President and CEO Candace S. Johnson, PhD, introduced the cancer center’s first Physician in Chief, Michael Wong, MD, and the slate of experts appointed to tackle the most pressing opportunities and challenges related to cancer treatment, outcomes and delivery of care.

Monday, December 2, 2024 - 07:00 am

Article

New MyRoswell app feature – photo sharing convenience!

The new version of the patient portal app – MyRoswell v1.0.34 – introduces a “Share To” feature that allows patients to easily upload photos, videos and documents directly from their individual Photo apps to their MyRoswell Media Library.

Saturday, November 30, 2024 - 01:14 pm

Cancer Support